InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SF1 | Ann: Response to ASX Query | 28/03/19 | 24 | 2.4K | |||
|
|||||||
SF1 | Ann: Trading Halt | 28/03/19 | 6 | 606 | |||
|
|||||||
SF1 | News: SF1 Stemify Seeks Trading Halt | 28/03/19 | 0 | 62 | |||
|
|||||||
SF1 | Ann: Pause in Trading | 28/03/19 | 0 | 105 | |||
|
|||||||
SF1 | Ann: Company Update - March 2019 | 18/03/19 | 13 | 6.6K | |||
|
|||||||
SF1 | Ann: Ceasing to be a substantial holder | 07/03/19 | 3 | 1.2K | |||
|
|||||||
SF1 | Ann: Appendix 4D and Half Year Report | 04/03/19 | 7 | 2.5K | |||
|
|||||||
SF1 | 2019 New chapter | 28/02/19 | 119 | 24K | |||
|
See All Discussions